Zymergen IPO

zymergen.com/

Zymergen was founded in 2013 by Jed Dean, Joshua Hoffman, and Zach Serber. The company has not officially endorsed a plan to participate in an IPO.

Zymergen is a science and material innovation company that develops and commercializes novel materials with a unique technology platform that combines biology, machine learning and automation. The company has raised nearly $900 million in Venture Capital funding from investors including Baillie Gifford, Baron Funds, Innovation Endeavors, Mission Bay Capital, Data Collective, Codon Capital, Two Sigma Investments, True Ventures, Threshold Ventures, Obvious Ventures, SoftBank Investment Advisers, Two Sigma Ventures, and Tao Capital Partners. Per company press releases, Zymergen last raised $300 million in September 2020 at a post-money valuation of approximately $1.75 billion.

Founded2013
Total Funding to Date$920.06MM
Register for Details

For more details on financing and valuation for Zymergen, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Zymergen Ticker Symbol

Zymergen does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Zymergen Stock Price

The stock price for Zymergen will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Zymergen Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
9/8/2020 Series D $1.75B $XXX.XX $XXX.XX
12/17/2018 Series C $1.05B $XXX.XX $XXX.XX
10/7/2016 Series B $455MM $XXX.XX $XXX.XX
6/4/2015 Series A $89.5MM $XXX.XX $XXX.XX
6/1/2015 Series A-1 $75.75MM $XXX.XX $XXX.XX
Based on primary financings

Other companies like Zymergen in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B